Approval · Notice of Compliance 9918 · 2008
PMS-OXYCODONE: Notice of Compliance 9918
Issued December 2, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9918
- Date
- December 2, 2008
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Opioid analgesic
- Canadian reference product
- OXY-IR (Purdue Pharma)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-OXYCODONE | 02319977 | Marketed |
| PMS-OXYCODONE | 02319985 | Marketed |
| PMS-OXYCODONE | 02319993 | Marketed |
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 5 MG per TAB
- OXYCODONE HYDROCHLORIDE 10 MG per TAB
- OXYCODONE HYDROCHLORIDE 20 MG per TAB